Sign In

3.25 : Steady State Concentration

A steady state refers to the level of a drug in the body once it has reached an equilibrium between administration and elimination. It represents the point at which the drug administration rate equals the drug elimination rate, resulting in a relatively constant concentration in the body over time. The dynamic equilibrium is crucial to ensure the drug's effectiveness with minimal risk of toxicity.

Most drugs are administered in repeated doses at fixed intervals or through continuous intravenous infusions to achieve a steady state. After each dose, the drug is absorbed, distributed, metabolized, and eliminated from the body. As subsequent doses are administered, the drug accumulates until the amount eliminated from the body in each dosing interval matches the amount administered. This leads to a stable concentration being maintained within a predictable range.

The rate at which a drug reaches a steady state depends on its half-life, which is the time it takes for the body to eliminate half of the drug. A drug typically takes around four to five half-lives to reach a steady state. During this time, the drug concentration gradually increases until it reaches a plateau where the administration and elimination rates become equal.

Once a steady state is achieved, the drug's concentration fluctuates within a narrow therapeutic range, ensuring a consistent pharmacological effect. Deviations from the steady-state concentration may lead to suboptimal treatment or increased risk of adverse effects. Factors such as patient characteristics, drug interactions, and changes in drug clearance should be considered when determining the optimal dosing strategy to achieve and maintain a steady state.

Tags
Steady State ConcentrationDrug AdministrationDrug EliminationDynamic EquilibriumDrug Half lifePharmacological EffectTherapeutic RangeDosing StrategyDrug InteractionsDrug Clearance

From Chapter 3:

article

Now Playing

3.25 : Steady State Concentration

Pharmacokinetics

3.6K Views

article

3.1 : Pharmacokinetics: Overview

Pharmacokinetics

2.9K Views

article

3.2 : Drug Absorption Mechanism: Passive Membrane Transport

Pharmacokinetics

2.7K Views

article

3.3 : Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Pharmacokinetics

2.8K Views

article

3.4 : Drug Absorption: Factors Affecting GI Absorption

Pharmacokinetics

3.1K Views

article

3.5 : Bioavailability: Overview

Pharmacokinetics

1.9K Views

article

3.6 : Factors Influencing Bioavailability: First-Pass Elimination

Pharmacokinetics

5.2K Views

article

3.7 : Bioequivalence: Overview

Pharmacokinetics

673 Views

article

3.8 : First Pass Effect

Pharmacokinetics

4.2K Views

article

3.9 : Time Course of Drug Effect

Pharmacokinetics

1.6K Views

article

3.10 : Drug Distribution: Tissue Binding

Pharmacokinetics

2.1K Views

article

3.11 : Physiological Barriers

Pharmacokinetics

2.9K Views

article

3.12 : Drug Distribution: Plasma Protein Binding

Pharmacokinetics

2.9K Views

article

3.13 : Compartment Models: Single-Compartment Model

Pharmacokinetics

1.7K Views

article

3.14 : Compartment Models: Two-Compartment Model

Pharmacokinetics

4.2K Views

See More

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved